Savara SVRA
NASDAQ SVRA
$5.37 +0.00 (+0.00%)
As of: Sep 4, 2026 · 3:59 PM EDT

Savara (SVRA) Other Working Capital Changes (2010 - 2026)

Savara (SVRA) posted quarterly Other Working Capital Changes of $639000.0 for Q1 2026, up 174.39% year-over-year from $232881.2 in Q1 2025, and down 72.85% quarter-over-quarter from $2.4 million in Q4 2025.

Analysis

Savara (SVRA) Other Working Capital Changes (2010 - 2026) Analysis & Trends

Savara (SVRA) has reported Other Working Capital Changes for 17 consecutive years, with $639000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Other Working Capital Changes rose 174.39% year-over-year to $639000.0; the TTM figure through Mar 2026 stood at $1.4 million (down 20.71% YoY), while the FY2025 annual figure was -$97000.0, down 104.07% from the prior year.
  • Other Working Capital Changes fell to $639000.0 in Q1 2026 per SVRA's latest filing, from $2.4 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $2.9 million in Q2 2024 and bottomed at -$1.6 million in Q1 2022.
  • Historically, Other Working Capital Changes has averaged $120294.1 across 5 years, with a median of -$116000.0 in 2023.
  • Annual changes were most pronounced in 2023 — Other Working Capital Changes plunged 1056.25% — and 2024, when it jumped 2617.24%.
  • Savara's Other Working Capital Changes stood at -$79000.0 in 2022, then surged by 2122.78% to $1.6 million in 2023, then tumbled by 160.95% to -$974000.0 in 2024, then soared by 341.68% to $2.4 million in 2025, then tumbled by 72.85% to $639000.0 in 2026.
  • Business Quant data shows SVRA's Other Working Capital Changes at $639000.0 in Q1 2026, $2.4 million in Q4 2025, and -$712000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Savara 1.36 Bn 1.36 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.48 Mn
Jun 30, 2026 -1.48 Mn
Mar 31, 2026 639,000.00
Mar 31, 2026 639,000.00
Dec 31, 2025 2.35 Mn
Dec 31, 2025 2.35 Mn
Sep 30, 2025 -712,000.00
Sep 30, 2025 -712,000.00
Jun 30, 2025 -880,000.00
Jun 30, 2025 -880,000.00
Mar 31, 2025 -859,000.00
Mar 31, 2025 -859,000.00
Dec 31, 2024 -974,000.00
Dec 31, 2024 -974,000.00
Sep 30, 2024 680,000.00
Sep 30, 2024 680,000.00
Jun 30, 2024 2.92 Mn
Jun 30, 2024 2.92 Mn
Mar 31, 2024 -243,000.00
Mar 31, 2024 -243,000.00